Will Iovance Biotherapeutics Inc (IOVA) Outperform the Rest of the Stocks in the Healthcare Sector?

Iovance Biotherapeutics Inc (IOVA) is around the top of the Healthcare sector according to InvestorsObserver. IOVA received an overall rating of 86, which means that it scores higher than 86% of stocks. Additionally, Iovance Biotherapeutics Inc scored a 98 in the Healthcare sector, ranking it higher than 98% of stocks in that sector.

IOVA has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on IOVA!

See Full IOVA Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 86 means the stock is more attractive than 86 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Iovance Biotherapeutics Inc Stock Today?

Iovance Biotherapeutics Inc (IOVA) stock is trading at $14.21 as of 12:03 PM on Wednesday, Mar 27, a rise of $0.15, or 1.1% from the previous closing price of $14.05. The stock has traded between $13.75 and $14.31 so far today. Volume today is low. So far 1,531,885 shares have traded compared to average volume of 13,743,229 shares. Click Here to get the full Stock Report for Iovance Biotherapeutics Inc stock.